id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0386-0009,FDA,FDA-2003-N-0386,HFA-305 to Pharmacetucial Distributors Association,Other,ACK-Acknowledgement Letter,2003-12-03T05:00:00Z,2003,12,,,2008-04-12T01:08:05Z,,0,0,09000064804a0d76
FDA-2003-N-0386-0008,FDA,FDA-2003-N-0386,Anti-Counterfeit Drug Initiative Public Meeting held 10/15/2003,Other,TR-Transcript,2003-11-12T05:00:00Z,2003,11,,,2008-04-12T01:08:11Z,,0,0,09000064804a0d5c
FDA-2003-N-0386-0006,FDA,FDA-2003-N-0386,Anti-Counterfeit Drug Initiative Public Meeting held 10/15/2003,Other,TR-Transcript,2003-11-12T05:00:00Z,2003,11,,,2008-04-12T01:08:09Z,,0,0,09000064804a0d59
FDA-2003-N-0386-0007,FDA,FDA-2003-N-0386,Anti-Counterfeit Drug Initiative Public Meeting held 10/15/2003,Other,TR-Transcript,2003-11-12T05:00:00Z,2003,11,,,2008-04-12T01:08:11Z,,0,0,09000064804a0d5b
FDA-2003-N-0386-0005,FDA,FDA-2003-N-0386,Anti-Counterfeit Drug Initiative Public Meeting held 10/15/2003,Other,TR-Transcript,2003-11-12T05:00:00Z,2003,11,,,2008-04-12T01:08:10Z,,0,0,09000064804a0d58
FDA-2003-N-0386-0004,FDA,FDA-2003-N-0386,"National Agency of Vigilancia Sanitaria (ANVISA), Brasil",Other,APE-Appearance Request,2003-10-02T04:00:00Z,2003,10,,,2008-04-12T01:08:07Z,,0,0,09000064804a0c52
FDA-2003-N-0386-0003,FDA,FDA-2003-N-0386,"National Agency of Vigilancia Sanitaria (ANVISA), Brasil",Other,APE-Appearance Request,2003-10-02T04:00:00Z,2003,10,,,2008-04-12T01:08:10Z,,0,0,09000064804a0c51
FDA-2003-N-0386-0002,FDA,FDA-2003-N-0386,FDA,Notice,NM-Notice of Meeting,2003-09-24T04:00:00Z,2003,9,2003-09-05T04:00:00Z,2003-11-04T04:59:59Z,2008-04-12T01:08:10Z,,0,0,09000064804a0c4b
FDA-2003-N-0386-0001,FDA,FDA-2003-N-0386,FDA,Notice,NCR-Notice of Correction,2003-09-15T04:00:00Z,2003,9,2003-09-12T04:00:00Z,2003-11-04T04:59:59Z,2008-04-12T01:08:08Z,,0,0,09000064804a0c18